THE DIAGNOSTIC PRINCIPLES FOR CIRRHOTIC CARDIOMYOPATHY.
Keywords:
cirrhotic cardiomyopathy, liver cirrhosis, cardiac dysfunction, management strategies, prognosisAbstract
Cirrhotic cardiomyopathy (CCM) is a specific form of cardiac dysfunction that develops in patients with liver cirrhosis and significantly affects clinical outcomes. Despite preserved or increased cardiac output at rest, patients demonstrate impaired systolic and diastolic responses to stress, as well as characteristic electrophysiological abnormalities. The condition remains underdiagnosed due to its latent clinical course, yet it plays a crucial role in perioperative morbidity and mortality, particularly in candidates for liver transplantation. This article provides a comprehensive review of current management strategies for cirrhotic cardiomyopathy, including pathophysiological mechanisms, diagnostic approaches, conservative and pharmacological treatment options, and perioperative considerations.
References
Asrani, S.K.; Devarbhavi, H.; Eaton, J.; Kamath, P.S. Burden of liver diseases in the world. J. Hepatol. 2019, 70, 151–171.
Australian Bureau of Statistics. Causes of Death, Australia, 2023. 2024. Available online: https://www.abs.gov.au/statistics/health/causes-death/causes-death-australia/2023 (accessed on 25 May 2025).
D’aMico, G.; Morabito, A.; D’aMico, M.; Pasta, L.; Malizia, G.; Rebora, P.; Valsecchi, M.G. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis. Hepatol. Int. 2017, 12, 34–43.
Farias, A.Q.; Vilalta, A.C.; Zitelli, P.M.; Pereira, G.; Goncalves, L.L.; Torre, A.; Diaz, J.M.; Gadano, A.C.; Mendes, L.S.; Alvares-Da-Silva, M.R.; et al. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America. Gastroenterology 2023, 165, 696–716.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1204–1222.
GBDD Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1160–1203.
Jepsen, P.; Younossi, Z.M. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. J. Hepatol. 2021, 75, S3–S13.
Moreau, R.; Jalan, R.; Gines, P.; Pavesi, M.; Angeli, P.; Cordoba, J.; Durand, F.; Gustot, T.; Saliba, F.; Domenicali, M.; et al. Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis. Gastroenterology 2013, 144, 1426–1437.e9.
Tonon, M.; D’aMbrosio, R.; Calvino, V.; Tosetti, G.; Barone, A.; Incicco, S.; Gambino, C.; Gagliardi, R.; Borghi, M.; Zeni, N.; et al. A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis. J. Hepatol. 2023, 80, 603–609.
Valery, P.C.; Clark, P.J.; Pratt, G.; Bernardes, C.M.; Hartel, G.; Toombs, M.; Irvine, K.M.; Powell, E.E. Hospitalisation for cirrhosis in Australia: Disparities in presentation and outcomes for Indigenous Australians. Int. J. Equity Health 2020, 19, 27.
Vaughn-Sandler, V.; Sherman, C.; Aronsohn, A.; Volk, M.L. Consequences of Perceived Stigma Among Patients with Cirrhosis. Dig. Dis. Sci. 2013, 59, 681–686.
Verma, N.; Kaur, P.; Garg, P.; Ranjan, V.; Ralmilay, S.; Rathi, S.; De, A.; Premkumar, M.; Taneja, S.; Roy, A.; et al. Clinical and Pathophysiological Characteristics of Non-Acute Decompensation of Cirrhosis. J. Hepatol. 2025, in press.
Azerbaijan
Türkiye
Uzbekistan
Kazakhstan
Turkmenistan
Kyrgyzstan
Republic of Korea
Japan
India
United States of America
Kosovo